Clinical Trial

Testing a Biometric Identification System to Improve Malaria Vaccine Completion

Recruiting
View on ClinicalTrials.gov →
Summary
Receiving all four doses of the malaria vaccine can significantly protect children against malaria illness, hospitalization, and death. However, in Ghana, only 46% of children complete the full vaccination sequence. More broadly, many children in Ghana do not receive the full set of recommended pediatric vaccinations. To address this, Simprints, in collaboration with Ghana Health Services, will implement a digital vaccination record system linked to biometrics. This system will automatically identify children who are behind on their vaccination schedule, providing health workers with information to prioritize community outreach. Additionally, it will send voice message reminders to caregivers to improve compliance. A cluster-randomized controlled trial (c-RCT) will be conducted in the Oti region to measure the impact of this innovation on the proportion of children completing malaria and routine vaccination schedules.
Trial Details
NCT Number NCT07261280
Lead Sponsor University of Michigan
Collaborators: University of Ghana, Harvard School of Public Health (HSPH)
Conditions Vaccination
Enrollment 4,715 participants
Start Date 2025-10-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-03